HUA LIEN INT'L (00969) released its interim results, reporting a loss attributable to shareholders of HKD 7.14 million, a year-on-year narrowing of 4.43%.
Hualian International (00969) announced its interim results for the six months ended June 30, 2026, with a turnover of HK$26.486 million, a year-on-year decrease of 63.96%; the loss attributable to shareholders narrowed to HK$7.14 million, a year-on-year improvement of 4.43%; basic loss per share was HK$0.3259.
HUA LIEN INT'L (00969) announced its interim results for the six months ended June 30, 2026, with a revenue of HKD 26.486 million, a year-on-year decrease of 63.96%; the loss attributable to shareholders was HKD 7.14 million, narrowing by 4.43% year-on-year; basic loss per share was HKD 0.3259.
The announcement stated that the decrease in revenue during the period was primarily due to a significant decline in the earnings of the sugar business segment.
Related Articles
.png)
GRAND PHARMA (00512) disclosed its 2026 semi-annual report: The advantages of the nuclear medicine industry strengthen global competitiveness, and the collaboration among multiple sectors opens up new spaces for growth.

MEIDONG AUTO (01268) released its interim results, reporting a loss attributable to shareholders of 275 million yuan, a year-on-year decrease of 66.19%.

GOLIK HOLDINGS (01118) announced its interim results, with the attributable profit to shareholders reaching HKD 71.572 million, an increase of 1.43% year-on-year.
GRAND PHARMA (00512) disclosed its 2026 semi-annual report: The advantages of the nuclear medicine industry strengthen global competitiveness, and the collaboration among multiple sectors opens up new spaces for growth.
.png)
MEIDONG AUTO (01268) released its interim results, reporting a loss attributable to shareholders of 275 million yuan, a year-on-year decrease of 66.19%.

GOLIK HOLDINGS (01118) announced its interim results, with the attributable profit to shareholders reaching HKD 71.572 million, an increase of 1.43% year-on-year.

RECOMMEND





